# Alan account plan

> Alan is a French prevention health insurer with €804m signed ARR (Q1 2026), about 1.14 million members and over 850 employees in four countries.

## At a glance

Alan, founded in 2016 by Jean-Charles Samuelian-Werve and Charles Gorintin, is a licensed health insurer that carries the risk itself and bundles cover with prevention services, care navigation, in-app doctors and Mo, its AI health companion. It insures employees of companies from one-person firms to large groups and public bodies, plus self-employed people and retirees, in France, Belgium, Spain and Canada, with more than 37,000 businesses as clients. It finished Q1 2026 with €804m in signed ARR and 1.1 million members, growing 53% year on year, and is profitable in France on an EBITDA basis. It has over 850 employees and is privately held; in June 2026 Prosus led a €480m Series G at a €5.5bn valuation.

## Business units

- **Health insurance**: The core: supplementary health and welfare cover customised for each company, with about 70% of claims reimbursed within 5 minutes; Alan also covers disability and accident insurance. Wins include the Ministry of Finance campaign covering 130,000 civil servants, closed with a 96% affiliation rate.
- **Mo and care services**: Mo, the AI health companion, became available to all insured adults in France in Q2 2026 and routes members to the right care; it sits alongside a virtual clinic, telemedicine and digital programmes. In Spain a Concierge AI books appointments by calling clinics.
- **Alan Précision**: Advanced prevention built after the acquisition of Aro: a blood test covering 80+ biomarkers, AI-supported analysis and a physician-supervised plan, in beta with a waitlist of approximately 11,000 members in Q2 2026.
- **Alan Play**: Gamified everyday activity, including step leagues with Kylian Mbappé's avatar and the Alan Cup across France, Belgium, Spain and Canada; cycling is being added with Berry rewards.
- **Alan Shop & Optique**: In-app optical and wellbeing products, including a French-manufactured premium line and Luxottica brands; revenue grew 80% year over year as of Q1 2026.
- **Occupational health (Prévenir)**: Occupational health through partner Prévenir, covering 14,000 employees across 100 companies; its centre at Alan's Paris office conducts more than 200 medical visits per week.

## Strategic priorities

- **International expansion**: The CEO aims to double the number of countries in the next 18 months, not only in Europe, and says Alan went from three countries to six; the Q2 2026 letter says several new markets beyond Europe and Canada are at an advanced stage.
- **From insurer to integrated healthcare platform**: Alan is consolidating prevention, access and wellbeing products and integrating them more deeply with insurance, aiming to lower its cost of claims through prevention.
- **AI-native operations**: 40% of care conversations are automated, agentic processes cover claims, fraud, underwriting and operations, and sales AI is on track for ~30% productivity gains in 2026.
- **Global multi-country tech stack**: Alan is rebuilding its technical stack into a global, multi-country architecture to enter new markets and reach new segments faster.
- **Public sector and new segments**: After winning ministries, Alan says a few major public tenders are underway, and it is growing strongly with retirees and the self-employed.
- **Global brand**: Health Can't Wait, a new global brand platform, was finalised in Q2 2026, with a first global campaign later in the year.

## Latest results

Alan finished Q1 2026 with €804m in signed ARR and 1.1 million members; new business acquisition rose 60% versus the previous year with roughly similar investments. By the end of Q2 2026 it had about 1.14 million members, and in September 2026 the CEO cited 1.2 million people covered and ARR growing 55% year on year. It is profitable in France and, per the CEO in October 2026, almost break even at group level, with several hundred million euros in cash. No numerical guidance is given.

## Investments and deals

- **Series G led by Prosus**: €480m at a €5.5bn valuation in June 2026, with Teachers' Venture Growth, Index Ventures and new investor Dara Holdings; total funding now past €1.2bn. Three months earlier Alan raised €100m at a €5bn valuation.
- **Acquisition of Aro**: Alan Précision was built following the acquisition of Aro; the Series G is also earmarked for fresh acquisitions.
- **AI and product development**: The round funds heavy spending on AI and health services, through technical teams rather than training large models, including Mo and the autonomous coding agent Hopper.
- **Occupational-health centre**: The Prévenir medical centre at Alan's Paris office, completed at the end of Q1 2026.

## Challenges and risks

- **Proving prevention works at scale**: The Next Web notes that insurers have promised to reward healthy behaviour for years with mixed results; showing that app nudges and AI improve health at scale is still to be proven.
- **Capital-intensive model**: Insurance needs reserves and expansion needs more capital; Alan is profitable in France but only almost break even at group level.
- **Regulation across new markets**: Each new country needs licences and regulatory processes; the Series G itself needed sign-off from France's financial authorities, and new country names are withheld pending regulators.
- **AI regulation in Europe**: The CEO opposes local AI regulation he says harms the industry and wants simpler rules, while Alan relies on AI in all functions.

## What leadership says

> "Health can't wait, not for symptoms to get worse, not for a six-month appointment, not for the system to catch up... We believe great health is a universal right, and that prevention should be too." — Jean-Charles Samuelian-Werve, Co-founder and CEO, The Next Web, Alan raises €480M led by Prosus, 2026-06-25

> "Our sales team has doubled productivity in the in the last 2 years" — Jean-Charles Samuelian-Werve, Co-founder and CEO, Couchonomics with Arjun podcast, 2026-09-29

> "We have more growth in front of us than behind us" — Jean-Charles Samuelian-Werve, Co-founder and CEO, 2026 Q2 Letter to Shareholders, 2026-08-31

> "Healthcare presents one of the most significant global opportunities for AI-led transformation" — Fahd Beg, Head of investments, Prosus Group, The Next Web, Alan raises €480M led by Prosus, 2026-06-25


## Where a supplier can help

- **Market-entry services**: Doubling the number of countries in 18 months creates needs for local recruitment, regulatory and actuarial advice, localisation and B2B distribution partners.
- **Healthcare provider and diagnostics partnerships**: Alan Précision, telemedicine and occupational health depend on lab, clinic and medical partners, in line with the shift to an integrated healthcare platform.
- **AI and data infrastructure**: AI-native operations and the global multi-country stack open room for AI tooling, evaluation, security and cloud suppliers that meet health-data rules.
- **Employer and public-sector channels**: Public tenders and the employer channel call for HR-software integrations, benefits platforms and bid support.
- **Brand and wellbeing content**: The global brand campaign and Alan Play's activity challenges fit media, sports and rewards partners.

_Tamtam's reading of the priorities and challenges above, not the company's own words._

## Key documents

### [Alan - 2026 Q2 Letter to Shareholders: investing in the next stage of growth](https://alan.com/en/blog/discover-alan/a/alan-2026-q2-letter-to-shareholders)

Report · 2026-08-31

- Alan is a French "prevention insurance" company: a licensed health insurer that bundles cover with prevention, care navigation and an AI health companion (Mo) in one app, sold mainly through employers.
- In June 2026 Prosus led Alan's €480 million Series G at a €5.5 billion valuation, its largest round to date; Prosus is pitched as a partner for international reach and consumer distribution.
- End of Q2 2026: ~€840m signed ARR and ~1.14 million members, 55% year-on-year growth, attributed to control of the cost of claims and operating efficiency from AI deployed at scale.
- International expansion "beyond Europe and Canada" is gathering pace, with several new markets at an advanced stage and major announcements promised soon.
- Product suite: Mo now open to all insured adults in France (engagement ~4x the human-powered Clinic); Alan Precision blood-test beta live with a ~11,000-member waitlist; Concierge AI voice booking in Spain finds an appointment in 70-80% of requests; Prévenir occupational-health centre in Paris runs 200+ medical visits a week.
- New global brand platform "Health Can't Wait"; the first global campaign is due later in 2026.
- Strategy rests on three structural advantages: vertical integration, a global-first platform and an AI-native operating model.

### [Alan - 2026 Q1 Letter to Shareholders (10th anniversary)](https://alan.com/en/blog/discover-alan/a/alan-2026-q1-letter-to-shareholders)

Report · 2026-05-06

- Q1 2026 closed at €804m signed ARR and 1.1 million members; Alan celebrated its 10th anniversary with the Alan10 keynote at the end of March.
- New business acquisition up 60% versus last year with roughly similar investment; 2025 results showed the France business profitable on an EBITDA basis.
- Mo, the AI health companion, live for 500k+ members in France with four times the engagement of the human-powered Clinic; 81% of members choose Mo even when they came looking for a doctor.
- Adjacent lines growing: Alan Shop revenue +80% year on year (optical incl. Luxottica brands); occupational health via Prévenir covers 14,000 employees across 100 companies; Alan Précision (from the Aro acquisition) has a 1,500+ waitlist.
- Public-sector win: the Ministry of Finance affiliation campaign (130,000 civil servants) closed at a 96% affiliation rate.
- AI as operating model: 40% of care conversations automated, 20-30% more pull requests per engineer, Sales AI targeting ~30% productivity gains in 2026 and one AI assistant per rep by 2027.
- Rebuilding the stack into a global multi-country architecture to enter new markets and segments faster; Kylian Mbappé partnership launched for brand building.

### [Alan raises €480M led by Prosus at a €5.5bn valuation (The Next Web)](https://thenextweb.com/news/alan-480m-prosus-prevention-insurance)

Report · 2026-06-25

- Series G of €480m ($550m) at a €5.5bn ($6.3bn) valuation, led by Prosus; existing backers Teachers' Venture Growth and Index Ventures joined, with new investor Dara Holdings. The round still needed regulatory sign-off, including from French financial authorities.
- It came three months after a €100m round at €5bn and takes Alan's total funding past €1.2bn.
- Business base: passed €800m ARR in Q1 2026 growing 53% year on year, more than 1.1 million members, profitable in France, more than 37,000 business clients, over 850 employees.
- Operates in France, Spain, Belgium and Canada; covers employees, self-employed professionals and retirees; regulated by the ACPR as an independent insurer, not a broker.
- Use of funds: new countries, deeper roots in existing markets, fresh acquisitions and heavy spending on AI and health services.
- Prosus (Naspers' investment arm) brings global consumer-platform experience and possible distribution in markets where Alan has no brand.

### [How Alan Built an €840 Million Health Insurance Business From Scratch (Couchonomics with Arjun)](https://www.youtube.com/watch?v=oVl7UcCnPDg)

Podcast · Jean-Charles Samuelian-Werve, Co-founder and CEO · 2026-09-29

- Alan is a full-stack insurer that carries the risk and rebuilt distribution, underwriting, claims, prevention services, telemedicine and digital programmes into one app; it calls the category "prevention insurance".
- Scale as stated: 1.2 million people covered, "830-40 million euros" of ARR (as transcribed) growing 55% year on year, four countries (France, Spain, Belgium, Canada), roughly 900 people; a round had just closed.
- Sells both B2C and B2B, from one-employee companies to very large employers, plus government entities (French Ministry of Finance, Prime Minister entities); demand is "everywhere", across hotels, restaurants, industry and retail.
- Engagement and service: 1 in 3 members weekly active, 1 in 10 daily; ~70% of claims reimbursed within 5 minutes; NPS 70; 85% to 87% of members would be disappointed if their employer switched away.
- AI: customer service roughly 50% automated, sales productivity doubled in 2 years; Mo is a doctor-in-the-loop AI companion and care navigator backed by 130+ health professionals.
- Next: double the number of countries in the next 18 months, "not only Europe"; Canada was the first new health-insurance licence there since 1957.
- Will not use health data to price risk: personalisation should change the experience and prevention plan, never the premium.

### [Esprit d'entreprise - Alan - Jean-Charles Samuelian (Le Figaro TV)](https://www.youtube.com/watch?v=7AFK0b-gRJQ)

Executive talk · Jean-Charles Samuelian-Werve, Co-founder and CEO · 2026-10-11

- Alan sells "prevention insurance": supplementary health and welfare (prévoyance) cover with prevention services built in, to companies of all sizes, the civil service, the self-employed and retirees; retirees and self-employed are a strongly growing segment.
- Stated scale: over a million members, turnover of 850 million euros, a €5.5 billion valuation; just raised 480 million euros.
- Profitable in France and almost break-even at group level, with "several hundred million euros in cash"; not looking for money, an IPO is not an end in itself, Europe and probably France preferred if it happens.
- Went "from three countries to six"; money goes to international expansion and AI/innovation.
- Public sector: won ministries (Finance, Ecology, Prime Minister's office) by preparing for a year and a half before the tenders; a few major tenders still under way.
- Service: 70% of reimbursements within 5 minutes, 98-99% within 24 hours; Mo AI companion; in Spain Mo calls clinics to book appointments.
- Kylian Mbappé is a shareholder and partner; Samuelian-Werve sits on Mistral AI's board and says Alan is "recruiting more than ever" despite heavy AI use.

## Questions about Alan

### What does Alan do?

Alan is a licensed health insurer that bundles health cover with prevention services, care navigation, in-app doctors and Mo, its AI health companion, for companies, self-employed people and retirees.

### What is Alan's revenue?

Alan finished Q1 2026 with €804m in signed ARR, growing 53% year on year; in October 2026 its CEO cited a turnover of 850 million.

### How many employees does Alan have?

Over 850 employees, according to The Next Web in June 2026; the CEO cited roughly 900 people in September 2026.

### Who leads Alan?

Jean-Charles Samuelian-Werve is co-founder and CEO; Charles Gorintin is the other co-founder.

### What is Alan's strategy?

Become an integrated prevention and healthcare platform, expand to new countries beyond Europe and Canada, and run an AI-native operating model on a global tech stack.

_Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)_
